Integrating BRAF/MEK inhibitors into combination therapy for melanoma

Por Smalley, K S M, Flaherty, K T
Publicado em 2009

Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif.

Por Baumann, U, Wu, S, Flaherty, K M, McKay, D B
Publicado em 1993

Crystal structure of yeast TATA-binding protein and model for interaction with DNA.

Por Chasman, D I, Flaherty, K M, Sharp, P A, Kornberg, R D
Publicado em 1993

Similarity of the three-dimensional structures of actin and the ATPase fragment of a 70-kDa heat shock cognate protein.

Por Flaherty, K M, McKay, D B, Kabsch, W, Holmes, K C
Publicado em 1991

Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts.

Por Burger, H, Weiser, B, Flaherty, K, Gulla, J, Nguyen, P N, Gibbs, R A
Publicado em 1991

Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor.

Por Zurawski, S M, Vega, F, Doyle, E L, Huyghe, B, Flaherty, K, McKay, D B, Zurawski, G
Publicado em 1993

Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels

Por Smalley, K S M, Contractor, R, Haass, N K, Lee, J T, Nathanson, K L, Medina, C A, Flaherty, K T, Herlyn, M
Publicado em 2007

Cloning, expression, and crystallization of recoverin, a calcium sensor in vision.

Por Ray, S, Zozulya, S, Niemi, G A, Flaherty, K M, Brolley, D, Dizhoor, A M, McKay, D B, Hurley, J, Stryer, L
Publicado em 1992

TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation

Por Meneghin, A., Choi, E. S., Evanoff, H. L., Kunkel, S. L., Martinez, F. J., Flaherty, K. R., Toews, G. B., Hogaboam, C. M.
Publicado no Histochem Cell Biol (2008)

Radiological versus histological diagnosis in UIP and NSIP: survival implications

Por Flaherty, K, Thwaite, E, Kazerooni, E, Gross, B, Toews, G, Colby, T, Travis, W, Mumford, J, Murray, S, Flint, A, Lynch, J, Martinez, F
Publicado em 2003

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

Por Paraiso, K H T, Fedorenko, I V, Cantini, L P, Munko, A C, Hall, M, Sondak, V K, Messina, J L, Flaherty, K T, Smalley, K S M
Publicado em 2010

Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia

Por Jakubzick, C, Choi, E S, Kunkel, S L, Evanoff, H, Martinez, F J, Puri, R K, Flaherty, K R, Toews, G B, Colby, T V, Kazerooni, E A, Gross, B H, Travis, W D, Hogaboam, C M
Publicado em 2004

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

Por Eisen, T, Ahmad, T, Flaherty, K T, Gore, M, Kaye, S, Marais, R, Gibbens, I, Hackett, S, James, M, Schuchter, L M, Nathanson, K L, Xia, C, Simantov, R, Schwartz, B, Poulin-Costello, M, O'Dwyer, P J, Ratain, M J
Publicado em 2006

Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia

Por Choi, E S, Pierce, E M, Jakubzick, C, Carpenter, K J, Kunkel, S L, Evanoff, H, Martinez, F J, Flaherty, K R, Moore, B B, Toews, G B, Colby, T V, Kazerooni, E A, Gross, B H, Travis, W D, Hogaboam, C M
Publicado em 2006